FRG Family Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FRG Family Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,250	Closed	-$203K	–	147
2024 Q4	$203K	Hold	2,250	–	–	0.04%	145
2024 Q3	$222K	Buy	2,250 +50	+2%	+$4.91K	0.04%	143
2024 Q2	$208K	Hold	2,200	–	–	0.04%	137
2024 Q1	$186K	Buy	+2,200	New	+$204K	0.04%	140
2023 Q2	–	Sell	-3,590	Closed	-$274K	–	144
2023 Q1	$274K	Hold	3,590	–	–	0.06%	127
2022 Q4	$298K	Hold	3,590	–	–	0.07%	124
2022 Q3	$285K	Hold	3,590	–	–	0.07%	119
2022 Q2	$267K	Buy	+3,590	New	+$269K	0.06%	124

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

FRG Family Wealth Advisors's XBI Position: Q1 2025 in Review

FRG Family Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 2,250 shares — an estimated $203K sold.

FRG Family Wealth Advisors first reported a position in XBI in Q2 2022 and held it in 8 quarters. The position peaked at $298K in Q4 2022. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

FRG Family Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
FRG Family Wealth Advisors sold 2,250 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $203K.
FRG Family Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 8 quarters.
FRG Family Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $298K in Q4 2022.
682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on FRG Family Wealth Advisors's 13F filing for Q1 2025, filed 15 May 2025.